Investment to develop pain therapy
20 October, 2005
A pain drug development company spun out of The University of Queensland has received a $3.25 million investment commitment to develop its innovative pain therapy.
Salivary bacteria as indicators of oral cancer
18 October, 2005
Patients suffering from oral cancer have increased levels of certain bacteria in their saliva, according to research published in the Open Access journal, Journal of Translational Medicine. Six common species of bacteria were found at significantly higher levels in the saliva of patients with oral squamous cell carcinoma (OSCC) than in the saliva of healthy individuals. The researchers were able to use three of the six species as a diagnostic tool to predict more than 80% of oral cancer cases. These preliminary findings indicate that three species of bacteria may be incidentally or causally linked with OSCC, and if so detection of these species could be used as a simple, rapid and non-invasive saliva test to diagnose oral cancer.
Single cell research
13 October, 2005
Using a water droplet 1 trillion times smaller than a litre of soda as a sort of nanoscale test tube, a University of Washington scientist is conducting chemical analysis and experimentation at unprecedented tiny scales.
A wee step forward
12 October, 2005
Physicists in Singapore have created the first paper battery that generates electricity from urine.
What is the Science Industry Action Agenda?
08 October, 2005 by Kristin Dewey | Supplied by: Science Industry Australia
The Australian science industry has grown in the last few years. While the progress being made by Australian industries is impressive, there are still many ways in which to improve efficiency and marketability on a global market
Banana and mosquito research
13 August, 2005
Two researchers from Queensland are contributing to a $436 million global plan to improve the health of millions of people in some of the world's poorest countries.
Marine research may benefit cancer patients
04 July, 2005
A team of international scientists – including Australians – has made a breakthrough in solving the problem that had put the development of marine-derived pharmaceuticals on hold for years.
Solvent recovery unit
20 June, 2005 | Supplied by: http://www.novasys.com.au/
Ofru Recycling has introduced a solvent recovery system with the ASC-150 that meets the ATEX European safety standard and contains an integrated steam heating system, rather than the conventional thermal oil heating system.
Researchers get first peek at amyloid's spine
09 June, 2005
Researchers at the Howard Hughes Medical Institute in US have provided the first detailed look at the core structure of the abnormal protein filaments found in at least 20 devastating diseases, ranging from Alzheimer's to Creutzfeldt-Jakob disease, the human version of “mad cow†disease.
CSIRO robots team up with MIT
01 June, 2005
Australian robotics research has received some fresh input as a new partnership between the CSIRO and the MIT computer science and artificial intelligence laboratory in USA has been formed.
Dye to pinpoint diseases
23 May, 2005
University of Toronto researchers have designed a chemical screening tool that will light up when dangerous pathogens and diseases in air, water and bodily fluids are present.
Marine invader under monitoring
18 May, 2005
Scientists have developed a genetic tool to help environmental authorities monitor the spread and impact of Australia's most invasive marine species, the New Zealand screwshell.
Mouse models
13 May, 2005 | Supplied by: http://www.artisoptimus.com/
ArtisOptimus and Taconic Farms are jointly using their strengths in MEF production and patented mouse models to bring a collection of primary mouse embryonic fi-broblasts to the research com-munity, under the brand name OptiMEF.
Animal-friendly herbicide in development
13 May, 2005
Scientists at Monash University are researching an environmentally friendly alternative to herbicides that targets weeds but does not affect animals. This research could also lead to new treatments for the internationally alarming health issue of tuberculosis infection.
Screening drugs of abuse by LC/MS
08 May, 2005 | Supplied by: Keysight Technologies Australia Pty Ltd
High throughput screening of drugs of abuse is performed at St Olav Hospital by LC/MS. Typically done by immunoassay, this overview describes the procedures for using this highly selective and quantitative LC/MS methodology
